Table of Contents
Analgesics in South Korea
Euromonitor International
May 2009
List
of Contents and Tables
Executive Summary
Continued Slowdown in
2008
More OTC Products Are Expected To Switch To Quasi-drugs
Fast
Growth of the Rx Market Hinders Growth of OTC Healthcare
Active Movement
in New Product Developments and the Acquisition of Patents
Product Margins
for Pharmacists Affect Sales of OTC Products
Key Trends and
Developments
Manufacturers' Efforts in Research and the Acquisition of
Patents
Economy Slowdown Affects OTC Healthcare in Korea
More OTC
Healthcare Products Are Expected To Switch To Quasi-drugs
Distribution
Channels Are More Diverse During the Review Period
Suppliers Appease
Pharmacists With High Margins
Market Indicators
Table 1 Consumer
Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life
Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by
Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution
Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by
Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by
Sector: % Value Growth 2008-2013
Appendix
OTC Registration and
Classification
Vitamins & Dietary Supplements Registration and
Classification
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Summary 1 Research Sources
Daewoong
Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 2
Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong
Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics
2007
Competitive Positioning
Summary 5 Daewoong Pharmaceutical Co Ltd:
Competitive Position 2008
Dong Wha Pharmaceutical Industrial Co Ltd
Strategic Direction
Key Facts
Summary 6 Dong Wha Pharmaceutical
Industrial Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Industrial
Co Ltd: Operational Indicators
Company Background
Production
Summary 8 Dong Wha Pharmaceutical Industrial Co Ltd: Production Statistics
Competitive Positioning
Summary 9 Dong Wha Pharmaceutical Industrial Co
Ltd: Competitive Position 2008
Dong-a Pharmaceutical Co Ltd
Strategic
Direction
Key Facts
Summary 10 Dong-A Pharmaceutical Co Ltd: Key
Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Summary 12 Dong-A Pharmaceutical Co Ltd:
Production Statistics
Competitive Positioning
Summary 13 Dong-A
Pharmaceutical Co Ltd: Competitive Position 2008
Kwang Dong Pharm Co
Ltd
Strategic Direction
Key Facts
Summary 14 Kwang Dong Pharm Co
Ltd: Key Facts
Summary 15 Kwang Dong Pharm Co Ltd: Operational
Indicators
Company Background
Production
Summary 16 Kwang Dong
Pharm Co Ltd: Production Statistics 2008
Competitive Positioning
Summary 17 Kwang Dong Pharm Co Ltd: Competitive Position 2008
Sk Chemicals
Co Ltd
Strategic Direction
Key Facts
Summary 18 SK Chemicals Co
Ltd: Key Facts
Summary 19 SK Chemicals Co Ltd: Operational Indicators
Company Background
Production
Summary 20 SK Chemicals Co Ltd:
Production Statistics
Competitive Positioning
Summary 21 SK Chemical
Co Ltd: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of
Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by
Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical
Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value
Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value
2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17
Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18
Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
| 
View Cart
